Updated: December 13, 2023
1
Filter
Overview
- As per Volza’s Peru Import data, Gabapentin import shipments in Peru stood at 547, imported by 29 Peru Importers from 43 Suppliers.
- Peru imports most of its Gabapentin from India, China and United States .
- The top 3 importers of Gabapentin are United States with 19,727 shipments followed by Singapore with 5,997 and India at the 3rd spot with 3,896 shipments.
- Top 3 Product Categories of Gabapentin Imports in Peru are
These facts are updated till 13 Dec 2023, and are based on Volza's Peru Import dataPeru Import data of Gabapentin sourced from 70 countries export import shipments with names of buyers, suppliers, top Decision maker's contact information like Direct, phone, email and LinkedIn profiles.
Gabapentin import data of Peru - 547 import shipments
All Filters
Applied Filters
PeruX
Top HSN Code
By Shipments
By Name
Top Exporting Countries
By Shipments
By Name
India
(211)China
(194)United States
(70)Canada
(41)Italy
(23)France
(3)Ireland
(3)Mexico
(2)View More (8)
Top Importing Countries
By Shipments
By Name
Thailand
(275)Turkey
(271)Spain
(262)Brazil
(254)Netherlands
(237)South Korea
(232)Ecuador
(223)Mexico
(219)Israel
(202)Hong Kong
(197)Puerto Rico
(195)Egypt
(191)France
(177)Chile
(152)Bangladesh
(147)South Africa
(146)Nigeria
(142)Kenya
(141)Tanzania
(136)Guatemala
(129)Maldives
(121)Hungary
(119)Ukraine
(114)Oman
(106)Afghanistan
(105)Vanuatu
(96)Malaysia
(92)Nepal
(89)Russia
(88)Argentina
(86)Yemen
(85)Bolivia
(83)Seychelles
(74)Zimbabwe
(74)Morocco
(73)Saudi Arabia
(71)Mauritius
(64)Nicaragua
(64)Guyana
(63)Venezuela
(62)Iraq
(60)Panama
(57)Saint Lucia
(57)Somalia
(55)Iran
(53)Sudan
(52)British Virgin Islands
(50)Honduras
(49)Ethiopia
(48)Ghana
(45)Paraguay
(41)Colombia
(40)Portugal
(39)Uzbekistan
(37)Costa Rica
(36)Saint Kitts And Nevis
(36)Romania
(35)Finland
(33)Gambia
(33)Poland
(33)Cambodia
(31)China
(31)Uruguay
(30)Zambia
(29)Greece
(28)Taiwan
(28)Jordan
(22)Uganda
(20)Austria
(19)Japan
(19)Madagascar
(19)Algeria
(18)Burundi
(16)Croatia
(16)Dominican Republic
(16)Liberia
(16)Mozambique
(16)Slovakia
(16)Congo
(15)Ireland
(15)Sierra Leone
(14)Tunisia
(14)Barbados
(13)Italy
(13)Kazakhstan
(13)Lebanon
(13)Syria
(13)FTZ - Tierra Del Fuego
(12)Djibouti
(11)Haiti
(11)Malawi
(11)Micronesia
(11)Georgia
(10)Guinea
(10)Namibia
(10)Cyprus
(9)Dominica
(9)Belarus
(8)Rwanda
(8)Latvia
(7)New Zealand
(7)Sweden
(7)Bahrain
(6)Kyrgyzstan
(6)Cameroon
(4)Guinea Bissau
(4)Papua New Guinea
(4)Bahamas
(3)Botswana
(3)Denmark
(3)El Salvador
(3)Lithuania
(3)Mali
(3)Saint Vincent And The Grenadines
(3)Tajikistan
(3)Angola
(2)Bhutan
(2)Cuba
(2)Jamaica
(2)Niger
(2)Trinidad and Tobago
(2)Antigua and Barbuda
(1)Aruba
(1)Belize
(1)Benin
(1)Ivory Coast
(1)North Korea
(1)East Timor
(1)Eritrea
(1)Fiji
(1)Iceland
(1)Kosovo
(1)Laos
(1)Serbia And Montenegro
(1)Swaziland
(1)Togo
(1)View More (156)
Top Related HSN Code
By Shipments
By Name
2922
(20)2933
(18)2934
(15)2941
(11)3002
(6)Top Related Products
By Shipments
By Name
View More (20)
Export Data by Country
By Shipments
By Name
Spain
(99)Argentina
(81)Malaysia
(79)Panama
(73)Malta
(48)Australia
(31)Netherlands Antilles
(24)Japan
(23)Bahamas
(21)Indonesia
(21)Slovenia
(18)Uruguay
(14)Bulgaria
(13)Hungary
(13)Turkey
(13)Greece
(9)Portugal
(9)Belgium
(8)Namibia
(8)Puerto Rico
(8)United Arab Emirates
(8)Switzerland
(7)Cyprus
(6)Ireland
(6)Norway
(6)Jamaica
(5)South Africa
(5)Bangladesh
(3)North Korea
(3)Morocco
(3)Netherlands
(3)Taiwan
(3)El Salvador
(2)Guatemala
(2)Mexico
(2)Philippines
(2)Swaziland
(2)Algeria
(1)Austria
(1)Guadeloupe
(1)Guam
(1)Romania
(1)Saudi Arabia
(1)Thailand
(1)Vietnam
(1)View More (62)
Top Buyer Countries
By Shipments
By Name
Afghanistan
(46)Germany
(40)United Arab Emirates
(37)Spain
(36)Nigeria
(36)Sri Lanka
(33)Ecuador
(33)Bangladesh
(33)South Korea
(31)Mexico
(31)Guatemala
(30)Tanzania
(29)Chile
(28)Peru
(27)Thailand
(27)Hong Kong
(27)Netherlands
(25)Yemen
(25)Australia
(23)Kenya
(23)Venezuela
(23)Switzerland
(22)Iraq
(22)Israel
(21)Ukraine
(21)Nepal
(21)Russia
(21)Somalia
(21)Nicaragua
(20)Belgium
(19)Guyana
(19)Sudan
(19)France
(18)Seychelles
(18)Uzbekistan
(18)Maldives
(16)Argentina
(16)Zimbabwe
(15)Iran
(15)Honduras
(15)Hungary
(14)Zambia
(14)Ethiopia
(13)Cambodia
(13)Jordan
(13)South Africa
(12)Malaysia
(12)Malta
(10)Slovenia
(10)Oman
(10)Mauritius
(10)Saint Lucia
(10)British Virgin Islands
(10)Colombia
(10)Saint Kitts And Nevis
(10)Algeria
(10)Lebanon
(10)Bolivia
(9)Panama
(9)Portugal
(9)Costa Rica
(9)Romania
(9)Liberia
(9)Saudi Arabia
(8)China
(8)Uganda
(8)Mozambique
(8)Paraguay
(7)Dominican Republic
(7)Italy
(7)Puerto Rico
(6)Ghana
(6)Gambia
(6)Taiwan
(6)Japan
(6)Madagascar
(6)Croatia
(6)Syria
(6)Djibouti
(6)Malawi
(6)Namibia
(6)Czech Republic
(5)Vanuatu
(5)Poland
(5)Congo
(5)Tunisia
(5)Dominica
(5)Belarus
(5)Sweden
(5)Kyrgyzstan
(5)Uruguay
(4)Greece
(4)Austria
(4)Burundi
(4)Ireland
(4)Barbados
(4)Kazakhstan
(4)Haiti
(4)Micronesia
(4)Georgia
(4)Guinea
(4)Latvia
(4)Bahrain
(4)Cameroon
(4)Morocco
(3)Finland
(3)Sierra Leone
(3)Cyprus
(3)Rwanda
(3)El Salvador
(3)Lithuania
(3)Slovakia
(2)Papua New Guinea
(2)Bahamas
(2)Botswana
(2)Saint Vincent And The Grenadines
(2)Tajikistan
(2)Jamaica
(2)Guinea Bissau
(1)Denmark
(1)Mali
(1)Angola
(1)Bhutan
(1)Cuba
(1)Niger
(1)Trinidad and Tobago
(1)Antigua and Barbuda
(1)Aruba
(1)Belize
(1)Benin
(1)Ivory Coast
(1)North Korea
(1)East Timor
(1)Eritrea
(1)Fiji
(1)Iceland
(1)Kosovo
(1)Laos
(1)Serbia And Montenegro
(1)Swaziland
(1)Togo
(1)FTZ - Tierra Del Fuego
(0)New Zealand
(0)View More (156)
Top Supplier Countries
By Shipments
By Name
Canada
(34)Singapore
(30)France
(28)Sri Lanka
(27)Spain
(25)Germany
(22)Italy
(22)United Kingdom
(19)Oman
(18)South Korea
(14)Egypt
(13)Dominican Republic
(11)Malaysia
(11)Pakistan
(9)Colombia
(8)Panama
(7)Bahamas
(7)Indonesia
(7)Argentina
(6)Israel
(5)Malta
(5)Australia
(5)Japan
(5)Hungary
(5)Belgium
(5)South Africa
(5)Turkey
(4)Portugal
(4)United Arab Emirates
(4)Switzerland
(4)Netherlands Antilles
(3)Bulgaria
(3)Namibia
(3)Jamaica
(3)Morocco
(3)Netherlands
(3)Slovenia
(2)Greece
(2)Ireland
(2)Philippines
(2)Swaziland
(2)Uruguay
(1)Puerto Rico
(1)Cyprus
(1)Norway
(1)Bangladesh
(1)North Korea
(1)Taiwan
(1)El Salvador
(1)Guatemala
(1)Mexico
(1)Algeria
(1)Austria
(1)Guadeloupe
(1)Guam
(1)Romania
(1)Saudi Arabia
(1)Thailand
(1)Vietnam
(1)View More (62)
HSN Code | Product Description | Origin | Destination | Qty. | Importer | Exporter |
|---|
| 2922499000 | GABAPENTIN USP37, S/M, S/M|KILOGRAMO|BATCH N¦ 06-20150117. MANUFACTURING DATE: 12.01.2015, EXPIRA DATE: 11.01.2018 | China | Peru | 250 |   | | |
| 2922499000 | GABAPENTINA, S/M, S/M | MATERIA PRIMA | PARA PREPARACION DE MEDICAMENTOS | GABAPENTIN | COMERCIALIZADO EN KILOS | China | Peru | 2100 | | | |
| 3004902900 | GABAPIN-300, 300MG // GABAPIN // S/M|LOTE: S04150, MFG: 04/2015, EXP: 03/2017|MEDICAMENTOS PARA USO HUMANO|1150X3X10C//CAPSULAS|GABAPIN-300, 300MG // GABAPENTIN CAPSULES 300MG//1150X3X10C | India | Peru | 1150 | | | |
| 3822009000 | ESTANDAR DE REFERENCIA, USP, S/M|GABAPENTIN (250MG)/60142-96-3|ESTANDAR DE REFERENCIA|EST-NDAR DE REFERENCIA GABAPENTINA 250 MG|LOT R020J0,CAT 1287303 | Italy | Peru | 1 | | | |
| 2922499000 | GABAPENTIN, S/M, S/M|06 TAMBORES DE 25.00 KG. C/U.|MATERIA PRIMA PARA USO FARMACEUTICO|LOTE NO. 20160302|MANUF.DATE : 2016.03.25 ; RETEST DATE : 2018-02.24 | China | Peru | 150 | | | 60 More Columns Available |
| 2922499000 | GABAPENTIN USP, S/M, S/M|15 TAMBORES DE 50.00 KGS.C/U|MATERIA PRIMA PARA USO FARMACEUTICO|LOTES NOS. 2-ST-0611215|MFG DATE : SEP-2015 ; RETEST DATE : AUG-2018 | India | Peru | 750 | | | |
| 3004902900 | GABAPENTINA 300 MG, LABOT, S/M|MEDICAMENTO PARA CONSUMO HUMANO FORMA DE PRESENTACION 500 TABLETAS/CAJA|DE USO PARA CONSUMO HUMANO|GABAPENTIN 300 MG TABLET|LOTE:656160301 F.VCTO:03/2019 | China | Peru | 2320 | | | |
| 2922499000 | GABAPENTINA COMPUESTO RELACIONADO D, USP, S/M|ESTANDARD PRIMARIO|PARA ANALISISI EN LABORATORIO|GABAPENTIN RELATED COMPOUND D - 10 MG|02 UNID X 10 MG // LOTE: G1K279,02 UNID | United States | Peru | 2 | | | |
| 3822003000 | GABAPENTIN, S/M, S/M|ESTANDARD DE REFERENCIA|LOT NUMBER: 160409-QCS-3|GABAPENTIN|MG/BOTTLE: 500 | United States | Peru | 4 | | | |
| 2922499000 | GABAPENTINA, S/M, S/M|INSUMOS PARA LA INDUSTRIA FARMACEUTICA|BATCH : 20160303 - ELAB.26.02.2016 - VENC. 25.02.2018|GABAPENTIN USP38|25KG/DRUM = 06 DRUMS | China | Peru | 150 | | | |
| 3004902900 | GABAPENTINA 300 MG, LABOT, S/M|MEDICAMENTO PARA CONSUMO HUMANO - PRESENTACION: 10 TABLETS/BLISTER, 50 BLISTER/BOX|BATCH NO. 656170705, 656170706, 656170707 MFG DATE:07-2017 EXP DATE: 07-2020|GABAPENTIN 300MG TABLET|. | China | Peru | 6960 | | | |
| 3004902900 | GABAPIN-300, 300MG // GABAPIN // S/M|LOTE: W02875, MFG: 02/2017, EXP: 01/2019|MEDICAMENTOS PARA USO HUMANO|4882X3X10C//CAPSULAS|GABAPIN-300, 300MG // GABAPENTIN CAPSULES USP 300MG//4882X3X10C | India | Peru | 4882 | | | |
| 2922499000 | GABAPENTINA COMPUESTO RELACIONADO D, USP, S/M|ESTANDARD PRIMARIO|PARA ANALISIS EN LABORATORIO|GABAPENTIN RELATED COMPOUND D - 10 MG|02 UNID X 10 MG // LOTE R01920 ,1287358 | United States | Peru | 2 | | | |
| 2922499000 | GABAPENTINA, USP, S/M|GABAPENTIN (250 MG)|ESTANDAR PRIMARIO PARA ANALISIS EN LABORATORIO|GABAPENTINA|LOTE N¦ R020J0 | Italy | Peru | 1 | | | |
| 2922499000 | GABAPENTIN, S/M, S/M|LOT 180135-QCS-20 // 15¦C-30¦C (CRT)|EN FRASCO DE 1000 MG|GABAPENTIN|ESTANDAR DE REFERENCIA | Ireland | Peru | 6 | | | |
| 2922499000 | GABAPENTIN RELATED COMPOUND, USP, S/M|ESTANDARES USP DE REFERENCIA|PARA ANALISIS DE LABORATORIO|CODIGO: 1287347 GABAPENTIN RELATED COMPOUND B (30 MG) ((1-CYANOCYCLOHEXYL) ACET | United States | Peru | 1 | | | |
| 3822009000 | ESTANDARES DE REFERENCIA, USP, S/M|GABAPENTIN 250MG|CODIGO: 1287303|.|250MG,ESTANDARES DE REFERENCIA PARA LABORATORIO | India | Peru | 1 | | | |
| 2933399000 | GABAPENTIN RELATED COMPOUND E|UN2811:1287369|(25 MG) (CARBOXYMETHYL- CYCLOHEXA|S/M S/M | United States | Peru | 1 | | | |
| 3822009000 | ESTANDARES DE REFERENCIA, USP, S/M|GABAPENTIN|CODIGO: 1287303|.|250MG,ESTANDARES DE REFERENCIA PARA LABORATORIO | India | Peru | 1 | | | |
| 2922499000 | GABAPENTIN RELATED COMPOUND A, USP, S/M|01 VIAL DE 50 MG|ESTANDARES DE REFERENCIA|CATALOG NUMBER : 1287325|(2-AZASPIRO(4.5)DECAN-3-ONE) / 64744-50-9 N | Canada | Peru | 1 | | | |
| 3004902900 | GABAPENTINA 300MG, LABOT, S/M|MEDICAMENTO PARA USO HUMANO (EN 10 TABLETS/BLISTER, 50 BLISTER/BOX)|LOTE 656191051, 656191052, 656191053, 656191059 FP 10/2019 FV 10/2022|GABAPENTIN 300 MG TABLETS|. | China | Peru | 8520 | | | |
| 3004902900 | GABAPENTINA 300MG, LABOT, S/M|MEDICAMENTO PARA USO HUMANO, PRESENTACI+N: (10 TABLETS/BLISTER, 10 BLISTER/BOX)|LOTE: 656191101, 656191102, 656191103, 656191104, 656191105, F. PROD.: 11/2019, F. VENC.:|GABAPENTIN 300 MG TABLETS|- | China | Peru | 58000 | | | |
| 2922499000 | GABAPENTIN, S/M, S/M|LOT 180659-QCS-3 // 15¦C-30¦C (CRT)|EN FRASCO DE 500 MG|GABAPENTIN|ESTANDAR DE REFERENCIA// SIN VALOR COMERCIAL,VALOR SOLO PARA ADUANA | United States | Peru | 5 | | | |
| 3004902900 | GABAPENTINA 300MG, LABOT, S/M|MEDICAMENTO PARA CONSUMO HUMANO, (10 TABLETS/BLISTER, 50 BLISTERS/BOX)|LTS: 656190506, 656190507, 656190508, 656190509, F.P: 05/2019 - F.V: 05/2022|GABAPENTIN 300MG TABLETS|. | China | Peru | 9200 | | | |
| 2917200000 | GABAPENTINA COMPUESTO RELACIONADO E, USP, S/M|ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO|1 UNIDAD X 25 MG / LOTE: R100X0 / CODIGO: 1287369|GABAPENTIN RELATED COMPOUND E (25 MG) | Canada | Peru | 1 | | | |
| 2922499000 | GABAPENTINA USP S/M|POLVO|REACTIVO DE REFERENCIA PARA ANALISIS DE INSUMOS FARMACEUTICOS|1287303 GABAPENTIN (250MG)|GABAPENTINA USP RS X 250MG CAT, FRASCO X 250MG | India | Peru | 1 | | | |
| 3004902900 | GABAPIN 300 GABAPIN S/M|PRESENTACION: 3X10C|MEDICAMENTO PARA USO HUMANO. ANTIEPILEPTICO|LOTE N¦ M2010089. MFD: 08/2020; EXP.DATE: 07/2022|GABAPIN 300 10 CAP (GABAPENTIN USP 300 MG) | India | Peru | 4223 | | | |
| 2933799000 | GABAPENTINA COMPUESTO RELACIONADO A, USP, S/M|ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO|1 UNIDAD X 50 MG / LOTE: R09870 / CODIGO: 1287325|GABAPENTIN RELATED COMPOUND A (50 MG)(2-AZASPIRO [4.5]DECAN-3-|R09870 | Canada | Peru | 1 | | | |
| 2922499000 | GABAPENTINA S/M S/M|25KG PER DRUM, IN 24 DRUMS|INSUMOS PARA LA INDUSTRIA FARMACEUTICA|GABAPENTIN USP42|BATCH N¦: 08-20200702D, EXP. DATE: 2023.06.27 | China | Peru | 600 | | | |
| 3004902900 | GABAPENTINA 300 MG, LABOT, S/M|MEDICAMENTO PARA CONSUMO HUMANO, FORMA PRESENTACION (10 TABLETS/BLISTER, 50 BLISTERS/BOX)|LOTE: 656201101 F.P.:11/2020 F.V.: 11/2023|GABAPENTIN 300 MG TABLET | China | Peru | 30 | | | |
| 3004902900 | GABAPENTINA 300 MG, LABOT, S/M|MEDICAMENTO PARA CONSUMO HUMANO, FORMA PRESENTACION (10 TABLETS/BLISTER, 50 BLISTERS/BOX)|LOTE: 656201001, 656201002, 656201003,F.P.:10/2020 F.V.:10/2023 -LOTE 656201101 F.P.:11/20|GABAPENTIN 300 MG TABLET | China | Peru | 7120 | | | |
| 2922499000 | GABAPENTINA , USP , S-M|ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO|1 UNIDAD X 250 MG - LOTE: R056D0 - CODIGO: 1287303|GABAPENTIN (250 MG) |R056D0 | India | Peru | 1 | | | |
| 3004902900 | GABAPIN 300 GABAPIN S-M|PRESENTACION: 60X3X10C|MEDICAMENTO PARA USO HUMANO. ANTIEPILEPTICO|GABAPENTINA 300 MG CAPSULAS. LOTE N¦ M2102957 , MFD: 03-2021 , EXP. 02-2023|GABAPIN 300 (GABAPENTIN CAPSULE 300 MG) 3004902900 HSN Code | India | Peru | 60 | | | |
| 3004902900 | GABAPIN 300 GABAPIN S-M|PRESENTACION: 60X3X10C|MEDICAMENTO PARA USO HUMANO. ANTIEPILEPTICO|GABAPENTINA 300 MG CAPSULAS. LOTE N¦ M2102956 , MFD: 03-2021 , EXP. 02-2023|GABAPIN 300 (GABAPENTIN USP CAPSULES 300 MG) HS_Code : 3004902900 | India | Peru | 60 | | | |
| 3004902900 | GABAPIN 300 GABAPIN S-M|REGISTRO SANITARIO N¦ EE-03129|MEDICAMENTO PARA USO HUMANO ANTIEPILEPTICO|GABAPIN 300 (GABAPENTIN USP 300 MG) |LOTE:M2107566 DATE MFG:05-2021 DATE EXP:04-2023 | India | Peru | 5820 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA USO HUMANO , PRESENTACI+N: (10 TABLETS-BLISTER , 10 BLISTERS-BOX) |LOTE: 656210603 , 656210604 , F. PROD.: 06-2021 , F. VENC.: 06-2024|GABAPENTIN 300 MG TABLETS|- | China | Peru | 23600 | | | |
| 3822900000 | GABAPENTINA , USP , S-M|EN FRASCO POR 250 MG. - LOTE: R056D0|ESTANDAR DE REFERENCIA PARA ANALISIS EN LABORATORIO|GABAPENTIN (250 MG) |1287303 | India | Peru | 1 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA CONSUMO HUMANO , PRESENTACION: (10 TABLETS-BLISTER , 50 BLISTERS-BOX ) |LOTE: 656220205 , 656220206 , 656220207 , 656220208 , 656220209 , 656220210 , 656220211|GABAPENTIN 300 MG TABLETS|656220212 , 656220213 , F. PROD.: 02-2022 , F. VENC.: 02-2025 | China | Peru | 18292 | | | |
| 2922499000 | GABAPENTIN RELATED COMPOUND A , USP , SIN MODELO|ESTANDARES USP DE REFERENCIA|PARA ANALISIS DE LABORATORIO|1287325 GABAPENTIN RELATED COMPOUND A (50 MG) (2-AZASPIRO[4.5]DECAN-3-ONE) | Canada | Peru | 1 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA CONSUMO HUMANO , PRESENTACION: (10 TABLETS-BLISTER , 50 BLISTERS-BOX ) |LOTE: 656220301 , F. PROD.: 03-2022 , VENC.: 03-2025|GABAPENTIN 300 MG TABLET|- | China | Peru | 1132 | | | |
| 3004902900 | GABAPENTINA 300 MG , LABOT , S-M|MEDICAMENTO PARA USO HUMANO (EN 10 TABLETS-BLISTER , 50 BLISTERS-BOX) |LOTES: 656211212 , 656211213 F.FAB: 12-2021 F.EXP: 12-2024|GABAPENTIN 300 MG TABLET|- | China | Peru | 51 | | | |
| 2922499000 | GABAPENTIN , S-M , S-M|BATCH N° CGBE220014|INSUMO PARA LA INDUSTRIA FARMACEUTICA|GABAPENTIN (EP) | India | Peru | 30 | | | |
| 3004902900 | GABAPENTIN USP , NEUROCAD-300 , S-M|GABAPENTIN USP CAPSULAS 300 MG (CAJA POR 100 CAPSULAS) |CONSUMO HUMANO-MEDICAMENTO|NEUROCAD-300 (GABAPENTIN CAPSULES 300MG) |BATCH: D335 -D336 -D337 - MANUFACTURING: 07-2022 - EXPIRY: 01-2025 | India | Peru | 11824 | | | |
| 3004902900 | GABAPENTINA 300MG, LABOT, S-M|GABAPENTINA 300MG TABLETAS|MEDICAMENTO PARA USO HUMANO - PRESENTACION (10 TABLETS-BLISTER, 50 BLISTERS-BOX) |GABAPENTIN 300MG TABLETS|LOTES DE 656230807 AL 656230810 , F.FAB:08-2023 F.EXP:08-2026 | China | Peru | 14100 | | | |
| 30049081 | GABAPENTIN >> GABAPENTIN CAPSULES GABAPIN CAPSULES 300MG GABAPENTIN CAPSULES 300MG EACH HARD GELATIN CAPSULES CONTAINS: GABAPENTIN USP 300MG [1200X3X10C] | India | Peru | 36000 | | | |
| 30049081 | CAPSULES >> GELATIN CAPSULES GABAPIN 300MG CAPSULES EACH HARD GELATIN CAPSULES CONTAINS: GABAPENTIN USP 300MG WATER FOR INJECTION BP [835X3X10C] | India | Peru | 25050 | | | |
| 30049081 | GABAPENTIN >> CONT GABAPENTIN PH.DRU.& MED.:GABAPIN 300MG CAPSULES EACH HARD GELATIN CAPSULE CONT.GABAPENTIN USP 300MG [3X10C PER PACK] [GABAPENTIN] ; EA CH | India | Peru | 4882 | | | |
| 30049081 | GABAPENTIN >> CNT GABAPENTIN PHARMA DRUG&MED:GABAPIN300 10CAP E6 -GABAPENTIN ECH HARD GELATIN CAP CNT:GABAPENTIN USP300MG AS PER DOCUMENT ; 10CAP E6 -GAB APENTIN ; CNT:GABAPEN TIN | India | Peru | 6510 | | | |
| 30049081 | GABAPENTIN >> CONT GABAPENTIN PH.DRU.& MED.: GABAPIN 300MG CAPSULES EACH CAPSULES CONT. GABAPENTIN USP 300MG [3X10C PER PACK] [GABAPENTIN] ; E ACH ; 300MG [3X10C | India | Peru | 2040 | | | |
| 30049081 | GABAPENTIN >> PHARMACEUTICAL DRUG AND MEDICINE - GABAPIN 300 10 CAP E6 - GABAPENTIN AS PER DOCUMENT ; GABAP IN ; I NV | India | Peru | 138240 | | | |
| 3004902900 | NEUROTINA 300 MG TABLETA RECUBIERTA , NEUROTINA , S-M|LOTE NO. 23GT226 , 23GT227 , 23GT228; VENCE: 07-2026; RS. EE-10992|PRESENTACION: CAJA DE CTN DUPLEX POR 100 TABLETAS RECUEBIERTAS|NEUROTINA (GABAPENTIN TABLETS USP 300 MG) |EN ENVASE BLISTER PDE PVC-ALUMINO-OPA-ALUMINIO PLATEADO | India | Peru | 23000 | | | |
| 3004902900 | NEUROTINA 300 MG TABLETA RECUBIERTA , NEUROTINA , S-M|LOTE NO. 23GT226 , 23GT227 , 23GT228; VENCE: 07-2026; RS. EE-10992|PRESENTACION: CAJA DE CTN DUPLEX POR 100 TABLETAS RECUEBIERTAS|NEUROTINA (GABAPENTIN TABLETS USP 300 MG) |EN ENVASE BLISTER PDE PVC-ALUMINO-OPA-ALUMINIO PLATEADO | India | Peru | 29400 | | | |
| 30049099 | GABTURIN 300 MG PACK 10x10's GABAPENTIN CAPSULES USP 300 MG BATCH NO 23GC056TO 57 MANUFACTURING DT 08/2023 EXP DT 07/2026 BAT | India | Peru | 13950 | | | |
| 3004902900 | GAB-300 300MG CAPSULA|MEDICAMENTO PARA CONSUMO HUMANO|PRODUCTO TERMINADO|LOTE: 23GT087 , VTO.: 02-2026 (CAJA DE 3 X 10 TAB.) (GABAPENTIN TABLETS USP 300MG) | India | Peru | 11000 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA USO HUMANO - PRESENTACION: (10 TABLETS-BLISTER , 50 BLISTERS-BOX) |LT: 6565230801-6565230802-6565230803-6565230804-6565230805 F.F.: 08-2023 F.E.: 08-2026|GABAPENTIN 300MG TABLETS - GABAPENTINA 300MG TABLETAS|LT: 656230715-656230716-656230717-656230718 F.F.: 07-2023 F.E.: 07-2026 | China | Peru | 20025 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA USO HUMANO - PRESENTACION: (10 TABLETS-BLISTER , 50 BLISTERS-BOX) |LOTE: 656230806-656230807-656230808-656230809-656230810 F.F.08-2023 F.E.: 08-2026|GABAPENTIN 300MG TABLETS - GABAPENTINA 300MG TABLETAS | China | Peru | 39900 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA USO HUMANO - PRESENTACION: (10 TABLETS-BLISTER , 50 BLISTERS-BOX) |LOTE: 656230717 F.F.07-2023 F.E.: 07-2026|GABAPENTIN 300MG TABLETS - GABAPENTINA 300MG TABLETAS | China | Peru | 1272 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA USO HUMANO - PRESENTACION: (10 TABLETS-BLISTER , 50 BLISTERS-BOX) |LOTE: 656230801 F.F.08-2023 F.E.: 08-2026|GABAPENTIN 300MG TABLETS - GABAPENTINA 300MG TABLETAS | China | Peru | 116 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA USO HUMANO - PRESENTACION: (10 TABLETS-BLISTER , 50 BLISTERS-BOX) |LOTE: 656230701 , 656230702 , 656230703 , 656230704 , 656230705 , 656230706 , 656230707 , |GABAPENTIN 300MG TABLETS - GABAPENTINA 300MG TABLETAS|656230708 , 656230709 , 656230710 , 656230711 , 656230712 , 656230713 , 656230714 07.2023 - 07.2 | China | Peru | 33303 | | | |
| 3004902900 | GABAPIN 300 GABAPIN S-M|17745 X 3 X 10 C , REGISTRO:EE-03129|MEDICAMENTOS PARA USO HUMANO - ANTIEPILEPTICO|GABAPENTIN CAPSULES USP 300 MG|LOTE: M2310272 MFD: 08-2023 EXP: 07-2025 | India | Peru | 17745 | | | |
| 2922499000 | GABAPENTINA , S-M , S-M|BATCH N°: GAA-2305080 - MFG DATE: 2023-06 - RETEST DATE: 2026-05|INSUMO PARA LA INDUSTRIA FARMACEUTICA|GABAPENTIN|BATCH N°: GAA-2305072 - MFG DATE: 2023-05 - RETEST DATE: 2026-04 | China | Peru | 1000 | | | |
| 30049099 | NEUROCAD-300GABAPENTIN CAPS 300MG Eachhard gelat caps cont Gabapentin USP300mg B NO.D590TOD593 D600&D603 MANUFACTURING 08/23 EXP | India | Peru | 39013 | | | |
| 3004902900 | GABAPENTINA 300MG, LABOT, S-M|GABAPENTINA 300MG TABLETAS|MEDICAMENTO PARA USO HUMANO - PRESENTACION (10 TABLETS-BLISTER, 50 BLISTERS-BOX) |GABAPENTIN 300MG TABLETS|LOTES DE 656230601 AL 656230612 , F.FAB:06-2023 F.EXP:06-2026 | China | Peru | 26884 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|GABAPENTINA 300MG TABLETAS|MEDICAMENTO PARA USO HUMANO - PRESENTACION (10 TABLETS-BLISTER , 50 BLISTERS-BOX) |GABAPENTIN 300MG TABLETS|LOTES: 656230605 , 656230606 , 656230607 , 656230608 , 656230609 , 656230611 , 656230612; F.FAB: | China | Peru | 459 | | | |
| 2922499000 | GABAPENTINA S-M S-M|GABAPENTINA|INSUMOS PARA LA INDUSTRIA FARMACEUTICA|GABAPENTIN|LOTE:GAA-2305080 MFG DATE:06-2023 VCTO:05-2026 | China | Peru | 450 | | | |
| 2922499000 | GABAPENTIN , S-M , S-M|15°C-30°C (CRT) |ESTANDAR DE REFERENCIA - 1 VIAL (S) PER SALES UNIT ; 400 MG PER VIAL|GABAPENTIN CRS | France | Peru | 1 | | | |
| 3004902900 | GABAPIN 300 GABAPIN S-M|CAPSULAS , RS. EE-03129|MEDICAMENTO DE USO HUMANO: ANTIEPILEPTICO|6000X3X10C - LOTE. M2206565 , PROD. 05-2022 , VENCE. 04-2024|GABAPIN 300 (GABAPENTIN USP 300 MG) | India | Peru | 6000 | | | |
| 30049099 | MEDICAMENTOS PARA USO VETERINARIO (GABAPENTIN NRV) | Mexico | Peru | 10.50 | | | |
| 3004903000 | GABAPENTIN L NRV 250 MG , NORVET , S-M , |LOTE: 2212369 - CADUCIDAD: DIC-2025|MEDICAMENTO PARA CANINOS|GABAPENTIN L NRV|PRESENTACION: BLISTER POR 30 UNIDADES | Mexico | Peru | 300 | | | |
| 30049081 | PHARMA DRUGS AND MEDI GABAPIN 300 10 CAPE6 GABAPENTIN USP 300 MG AS PER INV | India | Peru | 180000 | | | |
| 3004902900 | GABTURIN 300 MG GLOBELA 300 MG|GABAPENTIN CAPSULES USP 300 MG|MEDICAMENTO CAPSULA|PRODUCTO FARMACEUTICO|35172 PACK - 470 CAJAS - 10X10´S BATCH NO 23GC021 TO 28 MFG DT 03-2023 EXP DT 02-2026 | India | Peru | 35172 | | | |
| 3004902900 | NEUROTINA 300 MG TABLETA RECUBIERTA , NEUROTINA , S-M|LOTE NO. 23GT208 , 23GT209 , 23GT210 , 23GT211; VENCE: 05-2026; RS. EE-10992|PRESENTACION: CAJA DE CTN DUPLEX POR 100 TABLETAS RECUEBIERTAS|NEUROTINA (GABAPENTIN TABLETS USP 300 MG) |EN ENVASE BLISTER PDE PVC-ALUMINO-OPA-ALUMINIO PLATEADO | India | Peru | 40000 | | | |
| 3004902900 | NEUROCAD-300 , NEUROCAD-300 , S-M|BATCH: D522 , D523 , D524 , D525. MANUFACTURING DT: 03-2023 , EXPIRY DT: 09-2025|USO: CONSUMO HUMANO - MEDICAMENTO|NEUROCAD-300 (GABAPENTIN CAPSULES 300MG) |CADA CÁPSULA CONTIENE: GABAPENTIN USP 300MG , DESCUENTO TOTAL: $500.00 - R.S. EE-10115 | India | Peru | 19560 | | | |
| 30049081 | GABTURIN 300 MG GABAPENTIN CAPSULES USP300 MG BATCH NO 23GC021 TO 28 MANUFACTURING DT03/2023 EXP DT 02/2026 | India | Peru | 35172 | | | |
| 30049081 | GABTURIN 300 MG GABAPENTIN CAPSULES USP | India | Peru | 39579 | | | |
| 3004902900 | GABAPENTINA 300 MG TABLETA , LABOT , S-M|MEDICAMENTO PARA USO HUMANO (EN 10 TABLETS-BLISTER , 10 BLISTERS-BOX ) |LOTE: 656230301 AL 656230304; FP: 03-2023 VCTO: 03-2026|GABAPENTIN 300 MG TABLET|- | China | Peru | 47321 | | | |
| 3004902900 | NEUROTINA 300 MG TABLETA RECUBIERTA , NEUROTINA , S-M|LOTE NO. GT23030 , GT23031; VENCE: 12-2025; RS. EE-10992|PRESENTACION: CAJA DE CTN DUPLEX POR 100 TABLETAS RECUEBIERTAS EN ENVASE BLISTER DE|NEUROTINA (GABAPENTIN TABLETS USP 300 MG) |PVC-ALUMINO-OPA-ALUMINIO PLATEADO | India | Peru | 10000 | | | |
| 30049099 | NEUROCAD-300 GABAPENTIN CAPSULES USP 300MG B/NO.D522 TO D525, M/DT.03/2023,E/DT.09/202519560X10X10 | India | Peru | 19560 | | | |
| 30049081 | GABTURIN 300 MG PACK 3x10's GABAPENTIN CAPSULES USP 300 MGBATCH NO 23GC016, MANUFACTURING DT 03/2023 EXP DT 02/2026 | India | Peru | 5025 | | | |
| 30049081 | GABTURIN 300 MG PACK 3x10's GABAPENTIN CAPSULES USP 300 MGBATCH NO 23GC016, MANUFACTURING DT 03/2023 EXP DT 02/2026 | India | Peru | 5025 | | | |
| 3004902900 | NEUROTINA 300 MG TABLETA , NEUROTINA , S-M|LOTE NO. GT23030; VENCE: 12-2025; RS. EE-10992|PRESENTACION: CAJA DE CTN DUPLEX POR 100 TABLETAS RECUEBIERTAS|NEUROTINA (GABAPENTIN TABLETS USP 300 MG) |EN ENVASE BLISTER PDE PVC-ALUMINO-OPA-ALUMINIO PLATEADO , FABRICANTE: GLOBELA PHARMA PVT. LT | India | Peru | 5000 | | | |
| 2922499000 | GABAPENTIN , S-M , S-M|BATCH N° CGBU220502|INSUMO PARA LA INDUSTRIA FARMACEUTICA|GABAPENTIN (USP) |MFG.DATE: 11-2022 EXP. DATE:10-2025 | India | Peru | 500 | | | |
| 2922499000 | GABAPENTIN RELATED COMPOUND E , USP , S-M|01 VIAL DE 25 MG|ESTANDARES DE REFERENCIA|CATALOG NUMBER: 1287369| (CARBOXYMETHYL-CYCLOHEXANECARBOXYLIC ACID) -67950-95-2-R100X0-EAR99 | Canada | Peru | 1 | | | |
| 3004902900 | GABAPENTINA 300 MG , LABOT , S-M|MEDICAMENTO PARA CONSUMO HUMANO , PRESENTACION (10 TABLETS-BLISTER , 50 BLISTERS-BOX) |LOTES: 656220901 , 656220902 ; F.PROD.: 09-2022 , F.VCTO.:09-2025|GABAPENTIN 300 MG TABLETS | China | Peru | 3550 | | | |
| 2922499000 | GABAPENTIN RELATED COMPOUND D , USP , SIN MODELO|ESTANDARES USP DE REFERENCIA|PARA ANALISIS DE LABORATORIO|1287358 GABAPENTIN RELATED COMPOUND D (10 MG) ([1- (3- OXO-2-AZA-SPIRO[4.5]DEC-2- YLMETHYL) | India | Peru | 1 | | | |
| 2922499000 | GABAPENTIN , SIN MARCA , SIN MODELO|BATCH: CGBU220275 , FECHA DE FAB: MAYO 2022 , FECHA DE VEN: ABRIL 2025|BATCH: CGBU220276 , FECHA DE FAB: MAYO 2022 , FECHA DE VEN: ABRIL 2025|GABAPENTIN USP , EN TAMBORES|BATCH: CGBU220277 , FECHA DE FAB: MAYO 2022 , FECHA DE VEN: ABRIL 2025 , PARA LA FABRICACION D | India | Peru | 3000 | | | |
| 30049099 | NEUROCAD-300 GABAPENTIN CAPSULES 300MG E | India | Peru | 11824 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA CONSUMO HUMANO , PRESENTACIaN: (10 TABLETS-BLISTER , 50 BLISTERS-BOX) |LOTE: 656220501 , 656220502 , F. PROD.: 05-2022 , F. VENC.: 05-2025|GABAPENTIN 300MG TABLETS|- | China | Peru | 2481 | | | |
| 2922499000 | GABAPENTINA COMP. RELAC B , USP , S-M|GABAPENTIN RELATED COMPOUND B (30 MG) ( (1-CYANOCYCLOHEXYL) ACETIC ACID) (COLD SHIPMENT) |ESTANDAR DE REFERENCIA PARA PRUEBAS DE LABORATORIO|VP-00298-SP|1287347 | United States | Peru | 1 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA CONSUMO HUMANO , PRESENTACIaN: (EN 10 TABLETS-BLISTER , 50 BLISTERS-BOX ) |LOTE: 656220503 , 656220504 , F. PROD.: 05-2022 , F. VENC.: 05-2025|GABAPENTIN 300MG TABLETS|- | China | Peru | 4614 | | | |
| 3004902900 | GAB-300 300MG CAPSULA|MEDICAMENTO PARA CONSUMO HUMANO|PRODUCTO TERMINADO|LOTE: 22GT003 , VTO.: 12-2024 (CAJA DE 3 X 10 TAB.) (GABAPENTIN TABLETS USP 300MG) | India | Peru | 9169 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA CONSUMO HUMANO , PRESENTACION: (10 TABLETS-BLISTER , 50 BLISTERS-BOX ) |LOTE: 656220301 , 656220302 , 656220303 , 656220304 , 656220305 , 656220306 , 656220307 , 6562203|GABAPENTIN 300 MG TABLET|656220310 , F. PROD.: 03-2022 , VENC.: 03-2025 | China | Peru | 22792 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA CONSUMO HUMANO , PRESENTACION: (10 TABLETS-BLISTER , 50 BLISTERS-BOX ) |LOTE: 656220301 , 656220302 , 656220303 , 656220304 , 656220305 , 656220306 , 656220307 , 6562203|GABAPENTIN 300 MG TABLET|656220310 , F. PROD.: 03-2022 , VENC.: 03-2025 | China | Peru | 22792 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA CONSUMO HUMANO , PRESENTACION: (10 TABLETS-BLISTER , 50 BLISTERS-BOX ) |LOTE: 656220301 , F. PROD.: 03-2022 , VENC.: 03-2025|GABAPENTIN 300 MG TABLET|- | China | Peru | 1132 | | | |
| 3822900000 | GABAPENTINA , USP , S-M|COMPUESTO ORGANICO - LOTE: R056D0|EST-NDARES DE REFERENCIA PARA AN-LISIS EN LABORATORIO.|GABAPENTIN (250MG) -60142-96-3-R056D0-EAR99-2922498050|CODIGO: 1287303 - GABAPENTINA (250 MG) | India | Peru | 1 | | | |
| 3822900000 | GABAPENTINA , USP , S-M|COMPUESTO ORGANICO - LOTE: R056D0|EST-NDARES DE REFERENCIA PARA AN-LISIS EN LABORATORIO.|GABAPENTIN (250MG) -60142-96-3-R056D0-EAR99-2922498050|CODIGO: 1287303 - GABAPENTINA (250 MG) | India | Peru | 1 | | | |
| 3004902900 | GABAPIN 300 GABAPIN S-M|REGISTRO SANITARIO N¦ EE-03129|MEDICAMENTO PARA USO HUMANO ANTIEPILEPTICO|GABAPIN 300 10 CAP (GABAPENTIN USP 300 MG) |LOTE:M2117024 DATE MFG:12-2021 DATE EXP:11-2023 | India | Peru | 17393 | | | |
| 3004902900 | GABAPIN 300 GABAPIN S-M|REGISTRO SANITARIO N¦ EE-03129|MEDICAMENTO PARA USO HUMANO ANTIEPILEPTICO|GABAPIN 300 10 CAP (GABAPENTIN USP 300 MG) |LOTE:M2117024 DATE MFG:12-2021 DATE EXP:11-2023 | India | Peru | 17393 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA CONSUMO HUMANO , PRESENTACION: (10 TABLETS-BLISTER , 50 BLISTERS-BOX ) |LOTE: 656220213 , F. PROD.: 02-2022 , F. VENC.: 02-2025|GABAPENTIN 300 MG TABLETS|- | China | Peru | 808 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA CONSUMO HUMANO , PRESENTACION: (10 TABLETS-BLISTER , 50 BLISTERS-BOX ) |LOTE: 656220213 , F. PROD.: 02-2022 , F. VENC.: 02-2025|GABAPENTIN 300 MG TABLETS|- | China | Peru | 808 | | |
DownloadHSN Code | Product Description | Origin | Destination | Qty. | Importer | Exporter |
|---|
| 2922499000 | GABAPENTIN USP37, S/M, S/M|KILOGRAMO|BATCH N¦ 06-20150117. MANUFACTURING DATE: 12.01.2015, EXPIRA DATE: 11.01.2018 | China | Peru | 250 | | | |
| 2922499000 | GABAPENTINA, S/M, S/M | MATERIA PRIMA | PARA PREPARACION DE MEDICAMENTOS | GABAPENTIN | COMERCIALIZADO EN KILOS | China | Peru | 2100 | | | |
| 3004902900 | GABAPIN-300, 300MG // GABAPIN // S/M|LOTE: S04150, MFG: 04/2015, EXP: 03/2017|MEDICAMENTOS PARA USO HUMANO|1150X3X10C//CAPSULAS|GABAPIN-300, 300MG // GABAPENTIN CAPSULES 300MG//1150X3X10C | India | Peru | 1150 | | | |
| 3822009000 | ESTANDAR DE REFERENCIA, USP, S/M|GABAPENTIN (250MG)/60142-96-3|ESTANDAR DE REFERENCIA|EST-NDAR DE REFERENCIA GABAPENTINA 250 MG|LOT R020J0,CAT 1287303 | Italy | Peru | 1 | | | |
| 2922499000 | GABAPENTIN, S/M, S/M|06 TAMBORES DE 25.00 KG. C/U.|MATERIA PRIMA PARA USO FARMACEUTICO|LOTE NO. 20160302|MANUF.DATE : 2016.03.25 ; RETEST DATE : 2018-02.24 | China | Peru | 150 | | | 60 More Columns Available |
| 2922499000 | GABAPENTIN USP, S/M, S/M|15 TAMBORES DE 50.00 KGS.C/U|MATERIA PRIMA PARA USO FARMACEUTICO|LOTES NOS. 2-ST-0611215|MFG DATE : SEP-2015 ; RETEST DATE : AUG-2018 | India | Peru | 750 | | | |
| 3004902900 | GABAPENTINA 300 MG, LABOT, S/M|MEDICAMENTO PARA CONSUMO HUMANO FORMA DE PRESENTACION 500 TABLETAS/CAJA|DE USO PARA CONSUMO HUMANO|GABAPENTIN 300 MG TABLET|LOTE:656160301 F.VCTO:03/2019 | China | Peru | 2320 | | | |
| 2922499000 | GABAPENTINA COMPUESTO RELACIONADO D, USP, S/M|ESTANDARD PRIMARIO|PARA ANALISISI EN LABORATORIO|GABAPENTIN RELATED COMPOUND D - 10 MG|02 UNID X 10 MG // LOTE: G1K279,02 UNID | United States | Peru | 2 | | | |
| 3822003000 | GABAPENTIN, S/M, S/M|ESTANDARD DE REFERENCIA|LOT NUMBER: 160409-QCS-3|GABAPENTIN|MG/BOTTLE: 500 | United States | Peru | 4 | | | |
| 2922499000 | GABAPENTINA, S/M, S/M|INSUMOS PARA LA INDUSTRIA FARMACEUTICA|BATCH : 20160303 - ELAB.26.02.2016 - VENC. 25.02.2018|GABAPENTIN USP38|25KG/DRUM = 06 DRUMS | China | Peru | 150 | | | |
| 3004902900 | GABAPENTINA 300 MG, LABOT, S/M|MEDICAMENTO PARA CONSUMO HUMANO - PRESENTACION: 10 TABLETS/BLISTER, 50 BLISTER/BOX|BATCH NO. 656170705, 656170706, 656170707 MFG DATE:07-2017 EXP DATE: 07-2020|GABAPENTIN 300MG TABLET|. | China | Peru | 6960 | | | |
| 3004902900 | GABAPIN-300, 300MG // GABAPIN // S/M|LOTE: W02875, MFG: 02/2017, EXP: 01/2019|MEDICAMENTOS PARA USO HUMANO|4882X3X10C//CAPSULAS|GABAPIN-300, 300MG // GABAPENTIN CAPSULES USP 300MG//4882X3X10C | India | Peru | 4882 | | | |
| 2922499000 | GABAPENTINA COMPUESTO RELACIONADO D, USP, S/M|ESTANDARD PRIMARIO|PARA ANALISIS EN LABORATORIO|GABAPENTIN RELATED COMPOUND D - 10 MG|02 UNID X 10 MG // LOTE R01920 ,1287358 | United States | Peru | 2 | | | |
| 2922499000 | GABAPENTINA, USP, S/M|GABAPENTIN (250 MG)|ESTANDAR PRIMARIO PARA ANALISIS EN LABORATORIO|GABAPENTINA|LOTE N¦ R020J0 | Italy | Peru | 1 | | | |
| 2922499000 | GABAPENTIN, S/M, S/M|LOT 180135-QCS-20 // 15¦C-30¦C (CRT)|EN FRASCO DE 1000 MG|GABAPENTIN|ESTANDAR DE REFERENCIA | Ireland | Peru | 6 | | | |
| 2922499000 | GABAPENTIN RELATED COMPOUND, USP, S/M|ESTANDARES USP DE REFERENCIA|PARA ANALISIS DE LABORATORIO|CODIGO: 1287347 GABAPENTIN RELATED COMPOUND B (30 MG) ((1-CYANOCYCLOHEXYL) ACET | United States | Peru | 1 | | | |
| 3822009000 | ESTANDARES DE REFERENCIA, USP, S/M|GABAPENTIN 250MG|CODIGO: 1287303|.|250MG,ESTANDARES DE REFERENCIA PARA LABORATORIO | India | Peru | 1 | | | |
| 2933399000 | GABAPENTIN RELATED COMPOUND E|UN2811:1287369|(25 MG) (CARBOXYMETHYL- CYCLOHEXA|S/M S/M | United States | Peru | 1 | | | |
| 3822009000 | ESTANDARES DE REFERENCIA, USP, S/M|GABAPENTIN|CODIGO: 1287303|.|250MG,ESTANDARES DE REFERENCIA PARA LABORATORIO | India | Peru | 1 | | | |
| 2922499000 | GABAPENTIN RELATED COMPOUND A, USP, S/M|01 VIAL DE 50 MG|ESTANDARES DE REFERENCIA|CATALOG NUMBER : 1287325|(2-AZASPIRO(4.5)DECAN-3-ONE) / 64744-50-9 N | Canada | Peru | 1 | | | |
| 3004902900 | GABAPENTINA 300MG, LABOT, S/M|MEDICAMENTO PARA USO HUMANO (EN 10 TABLETS/BLISTER, 50 BLISTER/BOX)|LOTE 656191051, 656191052, 656191053, 656191059 FP 10/2019 FV 10/2022|GABAPENTIN 300 MG TABLETS|. | China | Peru | 8520 | | | |
| 3004902900 | GABAPENTINA 300MG, LABOT, S/M|MEDICAMENTO PARA USO HUMANO, PRESENTACI+N: (10 TABLETS/BLISTER, 10 BLISTER/BOX)|LOTE: 656191101, 656191102, 656191103, 656191104, 656191105, F. PROD.: 11/2019, F. VENC.:|GABAPENTIN 300 MG TABLETS|- | China | Peru | 58000 | | | |
| 2922499000 | GABAPENTIN, S/M, S/M|LOT 180659-QCS-3 // 15¦C-30¦C (CRT)|EN FRASCO DE 500 MG|GABAPENTIN|ESTANDAR DE REFERENCIA// SIN VALOR COMERCIAL,VALOR SOLO PARA ADUANA | United States | Peru | 5 | | | |
| 3004902900 | GABAPENTINA 300MG, LABOT, S/M|MEDICAMENTO PARA CONSUMO HUMANO, (10 TABLETS/BLISTER, 50 BLISTERS/BOX)|LTS: 656190506, 656190507, 656190508, 656190509, F.P: 05/2019 - F.V: 05/2022|GABAPENTIN 300MG TABLETS|. | China | Peru | 9200 | | | |
| 2917200000 | GABAPENTINA COMPUESTO RELACIONADO E, USP, S/M|ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO|1 UNIDAD X 25 MG / LOTE: R100X0 / CODIGO: 1287369|GABAPENTIN RELATED COMPOUND E (25 MG) | Canada | Peru | 1 | | | |
| 2922499000 | GABAPENTINA USP S/M|POLVO|REACTIVO DE REFERENCIA PARA ANALISIS DE INSUMOS FARMACEUTICOS|1287303 GABAPENTIN (250MG)|GABAPENTINA USP RS X 250MG CAT, FRASCO X 250MG | India | Peru | 1 | | | |
| 3004902900 | GABAPIN 300 GABAPIN S/M|PRESENTACION: 3X10C|MEDICAMENTO PARA USO HUMANO. ANTIEPILEPTICO|LOTE N¦ M2010089. MFD: 08/2020; EXP.DATE: 07/2022|GABAPIN 300 10 CAP (GABAPENTIN USP 300 MG) | India | Peru | 4223 | | | |
| 2933799000 | GABAPENTINA COMPUESTO RELACIONADO A, USP, S/M|ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO|1 UNIDAD X 50 MG / LOTE: R09870 / CODIGO: 1287325|GABAPENTIN RELATED COMPOUND A (50 MG)(2-AZASPIRO [4.5]DECAN-3-|R09870 | Canada | Peru | 1 | | | |
| 2922499000 | GABAPENTINA S/M S/M|25KG PER DRUM, IN 24 DRUMS|INSUMOS PARA LA INDUSTRIA FARMACEUTICA|GABAPENTIN USP42|BATCH N¦: 08-20200702D, EXP. DATE: 2023.06.27 | China | Peru | 600 | | | |
| 3004902900 | GABAPENTINA 300 MG, LABOT, S/M|MEDICAMENTO PARA CONSUMO HUMANO, FORMA PRESENTACION (10 TABLETS/BLISTER, 50 BLISTERS/BOX)|LOTE: 656201101 F.P.:11/2020 F.V.: 11/2023|GABAPENTIN 300 MG TABLET | China | Peru | 30 | | | |
| 3004902900 | GABAPENTINA 300 MG, LABOT, S/M|MEDICAMENTO PARA CONSUMO HUMANO, FORMA PRESENTACION (10 TABLETS/BLISTER, 50 BLISTERS/BOX)|LOTE: 656201001, 656201002, 656201003,F.P.:10/2020 F.V.:10/2023 -LOTE 656201101 F.P.:11/20|GABAPENTIN 300 MG TABLET | China | Peru | 7120 | | | |
| 2922499000 | GABAPENTINA , USP , S-M|ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO|1 UNIDAD X 250 MG - LOTE: R056D0 - CODIGO: 1287303|GABAPENTIN (250 MG) |R056D0 | India | Peru | 1 | | | |
| 3004902900 | GABAPIN 300 GABAPIN S-M|PRESENTACION: 60X3X10C|MEDICAMENTO PARA USO HUMANO. ANTIEPILEPTICO|GABAPENTINA 300 MG CAPSULAS. LOTE N¦ M2102957 , MFD: 03-2021 , EXP. 02-2023|GABAPIN 300 (GABAPENTIN CAPSULE 300 MG) 3004902900 HSN Code | India | Peru | 60 | | | |
| 3004902900 | GABAPIN 300 GABAPIN S-M|PRESENTACION: 60X3X10C|MEDICAMENTO PARA USO HUMANO. ANTIEPILEPTICO|GABAPENTINA 300 MG CAPSULAS. LOTE N¦ M2102956 , MFD: 03-2021 , EXP. 02-2023|GABAPIN 300 (GABAPENTIN USP CAPSULES 300 MG) HS_Code : 3004902900 | India | Peru | 60 | | | |
| 3004902900 | GABAPIN 300 GABAPIN S-M|REGISTRO SANITARIO N¦ EE-03129|MEDICAMENTO PARA USO HUMANO ANTIEPILEPTICO|GABAPIN 300 (GABAPENTIN USP 300 MG) |LOTE:M2107566 DATE MFG:05-2021 DATE EXP:04-2023 | India | Peru | 5820 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA USO HUMANO , PRESENTACI+N: (10 TABLETS-BLISTER , 10 BLISTERS-BOX) |LOTE: 656210603 , 656210604 , F. PROD.: 06-2021 , F. VENC.: 06-2024|GABAPENTIN 300 MG TABLETS|- | China | Peru | 23600 | | | |
| 3822900000 | GABAPENTINA , USP , S-M|EN FRASCO POR 250 MG. - LOTE: R056D0|ESTANDAR DE REFERENCIA PARA ANALISIS EN LABORATORIO|GABAPENTIN (250 MG) |1287303 | India | Peru | 1 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA CONSUMO HUMANO , PRESENTACION: (10 TABLETS-BLISTER , 50 BLISTERS-BOX ) |LOTE: 656220205 , 656220206 , 656220207 , 656220208 , 656220209 , 656220210 , 656220211|GABAPENTIN 300 MG TABLETS|656220212 , 656220213 , F. PROD.: 02-2022 , F. VENC.: 02-2025 | China | Peru | 18292 | | | |
| 2922499000 | GABAPENTIN RELATED COMPOUND A , USP , SIN MODELO|ESTANDARES USP DE REFERENCIA|PARA ANALISIS DE LABORATORIO|1287325 GABAPENTIN RELATED COMPOUND A (50 MG) (2-AZASPIRO[4.5]DECAN-3-ONE) | Canada | Peru | 1 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA CONSUMO HUMANO , PRESENTACION: (10 TABLETS-BLISTER , 50 BLISTERS-BOX ) |LOTE: 656220301 , F. PROD.: 03-2022 , VENC.: 03-2025|GABAPENTIN 300 MG TABLET|- | China | Peru | 1132 | | | |
| 3004902900 | GABAPENTINA 300 MG , LABOT , S-M|MEDICAMENTO PARA USO HUMANO (EN 10 TABLETS-BLISTER , 50 BLISTERS-BOX) |LOTES: 656211212 , 656211213 F.FAB: 12-2021 F.EXP: 12-2024|GABAPENTIN 300 MG TABLET|- | China | Peru | 51 | | | |
| 2922499000 | GABAPENTIN , S-M , S-M|BATCH N° CGBE220014|INSUMO PARA LA INDUSTRIA FARMACEUTICA|GABAPENTIN (EP) | India | Peru | 30 | | | |
| 3004902900 | GABAPENTIN USP , NEUROCAD-300 , S-M|GABAPENTIN USP CAPSULAS 300 MG (CAJA POR 100 CAPSULAS) |CONSUMO HUMANO-MEDICAMENTO|NEUROCAD-300 (GABAPENTIN CAPSULES 300MG) |BATCH: D335 -D336 -D337 - MANUFACTURING: 07-2022 - EXPIRY: 01-2025 | India | Peru | 11824 | | | |
| 3004902900 | GABAPENTINA 300MG, LABOT, S-M|GABAPENTINA 300MG TABLETAS|MEDICAMENTO PARA USO HUMANO - PRESENTACION (10 TABLETS-BLISTER, 50 BLISTERS-BOX) |GABAPENTIN 300MG TABLETS|LOTES DE 656230807 AL 656230810 , F.FAB:08-2023 F.EXP:08-2026 | China | Peru | 14100 | | | |
| 30049081 | GABAPENTIN >> GABAPENTIN CAPSULES GABAPIN CAPSULES 300MG GABAPENTIN CAPSULES 300MG EACH HARD GELATIN CAPSULES CONTAINS: GABAPENTIN USP 300MG [1200X3X10C] | India | Peru | 36000 | | | |
| 30049081 | CAPSULES >> GELATIN CAPSULES GABAPIN 300MG CAPSULES EACH HARD GELATIN CAPSULES CONTAINS: GABAPENTIN USP 300MG WATER FOR INJECTION BP [835X3X10C] | India | Peru | 25050 | | | |
| 30049081 | GABAPENTIN >> CONT GABAPENTIN PH.DRU.& MED.:GABAPIN 300MG CAPSULES EACH HARD GELATIN CAPSULE CONT.GABAPENTIN USP 300MG [3X10C PER PACK] [GABAPENTIN] ; EA CH | India | Peru | 4882 | | | |
| 30049081 | GABAPENTIN >> CNT GABAPENTIN PHARMA DRUG&MED:GABAPIN300 10CAP E6 -GABAPENTIN ECH HARD GELATIN CAP CNT:GABAPENTIN USP300MG AS PER DOCUMENT ; 10CAP E6 -GAB APENTIN ; CNT:GABAPEN TIN | India | Peru | 6510 | | | |
| 30049081 | GABAPENTIN >> CONT GABAPENTIN PH.DRU.& MED.: GABAPIN 300MG CAPSULES EACH CAPSULES CONT. GABAPENTIN USP 300MG [3X10C PER PACK] [GABAPENTIN] ; E ACH ; 300MG [3X10C | India | Peru | 2040 | | | |
| 30049081 | GABAPENTIN >> PHARMACEUTICAL DRUG AND MEDICINE - GABAPIN 300 10 CAP E6 - GABAPENTIN AS PER DOCUMENT ; GABAP IN ; I NV | India | Peru | 138240 | | | |
| 3004902900 | NEUROTINA 300 MG TABLETA RECUBIERTA , NEUROTINA , S-M|LOTE NO. 23GT226 , 23GT227 , 23GT228; VENCE: 07-2026; RS. EE-10992|PRESENTACION: CAJA DE CTN DUPLEX POR 100 TABLETAS RECUEBIERTAS|NEUROTINA (GABAPENTIN TABLETS USP 300 MG) |EN ENVASE BLISTER PDE PVC-ALUMINO-OPA-ALUMINIO PLATEADO | India | Peru | 23000 | | | |
| 3004902900 | NEUROTINA 300 MG TABLETA RECUBIERTA , NEUROTINA , S-M|LOTE NO. 23GT226 , 23GT227 , 23GT228; VENCE: 07-2026; RS. EE-10992|PRESENTACION: CAJA DE CTN DUPLEX POR 100 TABLETAS RECUEBIERTAS|NEUROTINA (GABAPENTIN TABLETS USP 300 MG) |EN ENVASE BLISTER PDE PVC-ALUMINO-OPA-ALUMINIO PLATEADO | India | Peru | 29400 | | | |
| 30049099 | GABTURIN 300 MG PACK 10x10's GABAPENTIN CAPSULES USP 300 MG BATCH NO 23GC056TO 57 MANUFACTURING DT 08/2023 EXP DT 07/2026 BAT | India | Peru | 13950 | | | |
| 3004902900 | GAB-300 300MG CAPSULA|MEDICAMENTO PARA CONSUMO HUMANO|PRODUCTO TERMINADO|LOTE: 23GT087 , VTO.: 02-2026 (CAJA DE 3 X 10 TAB.) (GABAPENTIN TABLETS USP 300MG) | India | Peru | 11000 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA USO HUMANO - PRESENTACION: (10 TABLETS-BLISTER , 50 BLISTERS-BOX) |LT: 6565230801-6565230802-6565230803-6565230804-6565230805 F.F.: 08-2023 F.E.: 08-2026|GABAPENTIN 300MG TABLETS - GABAPENTINA 300MG TABLETAS|LT: 656230715-656230716-656230717-656230718 F.F.: 07-2023 F.E.: 07-2026 | China | Peru | 20025 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA USO HUMANO - PRESENTACION: (10 TABLETS-BLISTER , 50 BLISTERS-BOX) |LOTE: 656230806-656230807-656230808-656230809-656230810 F.F.08-2023 F.E.: 08-2026|GABAPENTIN 300MG TABLETS - GABAPENTINA 300MG TABLETAS | China | Peru | 39900 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA USO HUMANO - PRESENTACION: (10 TABLETS-BLISTER , 50 BLISTERS-BOX) |LOTE: 656230717 F.F.07-2023 F.E.: 07-2026|GABAPENTIN 300MG TABLETS - GABAPENTINA 300MG TABLETAS | China | Peru | 1272 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA USO HUMANO - PRESENTACION: (10 TABLETS-BLISTER , 50 BLISTERS-BOX) |LOTE: 656230801 F.F.08-2023 F.E.: 08-2026|GABAPENTIN 300MG TABLETS - GABAPENTINA 300MG TABLETAS | China | Peru | 116 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA USO HUMANO - PRESENTACION: (10 TABLETS-BLISTER , 50 BLISTERS-BOX) |LOTE: 656230701 , 656230702 , 656230703 , 656230704 , 656230705 , 656230706 , 656230707 , |GABAPENTIN 300MG TABLETS - GABAPENTINA 300MG TABLETAS|656230708 , 656230709 , 656230710 , 656230711 , 656230712 , 656230713 , 656230714 07.2023 - 07.2 | China | Peru | 33303 | | | |
| 3004902900 | GABAPIN 300 GABAPIN S-M|17745 X 3 X 10 C , REGISTRO:EE-03129|MEDICAMENTOS PARA USO HUMANO - ANTIEPILEPTICO|GABAPENTIN CAPSULES USP 300 MG|LOTE: M2310272 MFD: 08-2023 EXP: 07-2025 | India | Peru | 17745 | | | |
| 2922499000 | GABAPENTINA , S-M , S-M|BATCH N°: GAA-2305080 - MFG DATE: 2023-06 - RETEST DATE: 2026-05|INSUMO PARA LA INDUSTRIA FARMACEUTICA|GABAPENTIN|BATCH N°: GAA-2305072 - MFG DATE: 2023-05 - RETEST DATE: 2026-04 | China | Peru | 1000 | | | |
| 30049099 | NEUROCAD-300GABAPENTIN CAPS 300MG Eachhard gelat caps cont Gabapentin USP300mg B NO.D590TOD593 D600&D603 MANUFACTURING 08/23 EXP | India | Peru | 39013 | | | |
| 3004902900 | GABAPENTINA 300MG, LABOT, S-M|GABAPENTINA 300MG TABLETAS|MEDICAMENTO PARA USO HUMANO - PRESENTACION (10 TABLETS-BLISTER, 50 BLISTERS-BOX) |GABAPENTIN 300MG TABLETS|LOTES DE 656230601 AL 656230612 , F.FAB:06-2023 F.EXP:06-2026 | China | Peru | 26884 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|GABAPENTINA 300MG TABLETAS|MEDICAMENTO PARA USO HUMANO - PRESENTACION (10 TABLETS-BLISTER , 50 BLISTERS-BOX) |GABAPENTIN 300MG TABLETS|LOTES: 656230605 , 656230606 , 656230607 , 656230608 , 656230609 , 656230611 , 656230612; F.FAB: | China | Peru | 459 | | | |
| 2922499000 | GABAPENTINA S-M S-M|GABAPENTINA|INSUMOS PARA LA INDUSTRIA FARMACEUTICA|GABAPENTIN|LOTE:GAA-2305080 MFG DATE:06-2023 VCTO:05-2026 | China | Peru | 450 | | | |
| 2922499000 | GABAPENTIN , S-M , S-M|15°C-30°C (CRT) |ESTANDAR DE REFERENCIA - 1 VIAL (S) PER SALES UNIT ; 400 MG PER VIAL|GABAPENTIN CRS | France | Peru | 1 | | | |
| 3004902900 | GABAPIN 300 GABAPIN S-M|CAPSULAS , RS. EE-03129|MEDICAMENTO DE USO HUMANO: ANTIEPILEPTICO|6000X3X10C - LOTE. M2206565 , PROD. 05-2022 , VENCE. 04-2024|GABAPIN 300 (GABAPENTIN USP 300 MG) | India | Peru | 6000 | | | |
| 30049099 | MEDICAMENTOS PARA USO VETERINARIO (GABAPENTIN NRV) | Mexico | Peru | 10.50 | | | |
| 3004903000 | GABAPENTIN L NRV 250 MG , NORVET , S-M , |LOTE: 2212369 - CADUCIDAD: DIC-2025|MEDICAMENTO PARA CANINOS|GABAPENTIN L NRV|PRESENTACION: BLISTER POR 30 UNIDADES | Mexico | Peru | 300 | | | |
| 30049081 | PHARMA DRUGS AND MEDI GABAPIN 300 10 CAPE6 GABAPENTIN USP 300 MG AS PER INV | India | Peru | 180000 | | | |
| 3004902900 | GABTURIN 300 MG GLOBELA 300 MG|GABAPENTIN CAPSULES USP 300 MG|MEDICAMENTO CAPSULA|PRODUCTO FARMACEUTICO|35172 PACK - 470 CAJAS - 10X10´S BATCH NO 23GC021 TO 28 MFG DT 03-2023 EXP DT 02-2026 | India | Peru | 35172 | | | |
| 3004902900 | NEUROTINA 300 MG TABLETA RECUBIERTA , NEUROTINA , S-M|LOTE NO. 23GT208 , 23GT209 , 23GT210 , 23GT211; VENCE: 05-2026; RS. EE-10992|PRESENTACION: CAJA DE CTN DUPLEX POR 100 TABLETAS RECUEBIERTAS|NEUROTINA (GABAPENTIN TABLETS USP 300 MG) |EN ENVASE BLISTER PDE PVC-ALUMINO-OPA-ALUMINIO PLATEADO | India | Peru | 40000 | | | |
| 3004902900 | NEUROCAD-300 , NEUROCAD-300 , S-M|BATCH: D522 , D523 , D524 , D525. MANUFACTURING DT: 03-2023 , EXPIRY DT: 09-2025|USO: CONSUMO HUMANO - MEDICAMENTO|NEUROCAD-300 (GABAPENTIN CAPSULES 300MG) |CADA CÁPSULA CONTIENE: GABAPENTIN USP 300MG , DESCUENTO TOTAL: $500.00 - R.S. EE-10115 | India | Peru | 19560 | | | |
| 30049081 | GABTURIN 300 MG GABAPENTIN CAPSULES USP300 MG BATCH NO 23GC021 TO 28 MANUFACTURING DT03/2023 EXP DT 02/2026 | India | Peru | 35172 | | | |
| 30049081 | GABTURIN 300 MG GABAPENTIN CAPSULES USP | India | Peru | 39579 | | | |
| 3004902900 | GABAPENTINA 300 MG TABLETA , LABOT , S-M|MEDICAMENTO PARA USO HUMANO (EN 10 TABLETS-BLISTER , 10 BLISTERS-BOX ) |LOTE: 656230301 AL 656230304; FP: 03-2023 VCTO: 03-2026|GABAPENTIN 300 MG TABLET|- | China | Peru | 47321 | | | |
| 3004902900 | NEUROTINA 300 MG TABLETA RECUBIERTA , NEUROTINA , S-M|LOTE NO. GT23030 , GT23031; VENCE: 12-2025; RS. EE-10992|PRESENTACION: CAJA DE CTN DUPLEX POR 100 TABLETAS RECUEBIERTAS EN ENVASE BLISTER DE|NEUROTINA (GABAPENTIN TABLETS USP 300 MG) |PVC-ALUMINO-OPA-ALUMINIO PLATEADO | India | Peru | 10000 | | | |
| 30049099 | NEUROCAD-300 GABAPENTIN CAPSULES USP 300MG B/NO.D522 TO D525, M/DT.03/2023,E/DT.09/202519560X10X10 | India | Peru | 19560 | | | |
| 30049081 | GABTURIN 300 MG PACK 3x10's GABAPENTIN CAPSULES USP 300 MGBATCH NO 23GC016, MANUFACTURING DT 03/2023 EXP DT 02/2026 | India | Peru | 5025 | | | |
| 30049081 | GABTURIN 300 MG PACK 3x10's GABAPENTIN CAPSULES USP 300 MGBATCH NO 23GC016, MANUFACTURING DT 03/2023 EXP DT 02/2026 | India | Peru | 5025 | | | |
| 3004902900 | NEUROTINA 300 MG TABLETA , NEUROTINA , S-M|LOTE NO. GT23030; VENCE: 12-2025; RS. EE-10992|PRESENTACION: CAJA DE CTN DUPLEX POR 100 TABLETAS RECUEBIERTAS|NEUROTINA (GABAPENTIN TABLETS USP 300 MG) |EN ENVASE BLISTER PDE PVC-ALUMINO-OPA-ALUMINIO PLATEADO , FABRICANTE: GLOBELA PHARMA PVT. LT | India | Peru | 5000 | | | |
| 2922499000 | GABAPENTIN , S-M , S-M|BATCH N° CGBU220502|INSUMO PARA LA INDUSTRIA FARMACEUTICA|GABAPENTIN (USP) |MFG.DATE: 11-2022 EXP. DATE:10-2025 | India | Peru | 500 | | | |
| 2922499000 | GABAPENTIN RELATED COMPOUND E , USP , S-M|01 VIAL DE 25 MG|ESTANDARES DE REFERENCIA|CATALOG NUMBER: 1287369| (CARBOXYMETHYL-CYCLOHEXANECARBOXYLIC ACID) -67950-95-2-R100X0-EAR99 | Canada | Peru | 1 | | | |
| 3004902900 | GABAPENTINA 300 MG , LABOT , S-M|MEDICAMENTO PARA CONSUMO HUMANO , PRESENTACION (10 TABLETS-BLISTER , 50 BLISTERS-BOX) |LOTES: 656220901 , 656220902 ; F.PROD.: 09-2022 , F.VCTO.:09-2025|GABAPENTIN 300 MG TABLETS | China | Peru | 3550 | | | |
| 2922499000 | GABAPENTIN RELATED COMPOUND D , USP , SIN MODELO|ESTANDARES USP DE REFERENCIA|PARA ANALISIS DE LABORATORIO|1287358 GABAPENTIN RELATED COMPOUND D (10 MG) ([1- (3- OXO-2-AZA-SPIRO[4.5]DEC-2- YLMETHYL) | India | Peru | 1 | | | |
| 2922499000 | GABAPENTIN , SIN MARCA , SIN MODELO|BATCH: CGBU220275 , FECHA DE FAB: MAYO 2022 , FECHA DE VEN: ABRIL 2025|BATCH: CGBU220276 , FECHA DE FAB: MAYO 2022 , FECHA DE VEN: ABRIL 2025|GABAPENTIN USP , EN TAMBORES|BATCH: CGBU220277 , FECHA DE FAB: MAYO 2022 , FECHA DE VEN: ABRIL 2025 , PARA LA FABRICACION D | India | Peru | 3000 | | | |
| 30049099 | NEUROCAD-300 GABAPENTIN CAPSULES 300MG E | India | Peru | 11824 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA CONSUMO HUMANO , PRESENTACIaN: (10 TABLETS-BLISTER , 50 BLISTERS-BOX) |LOTE: 656220501 , 656220502 , F. PROD.: 05-2022 , F. VENC.: 05-2025|GABAPENTIN 300MG TABLETS|- | China | Peru | 2481 | | | |
| 2922499000 | GABAPENTINA COMP. RELAC B , USP , S-M|GABAPENTIN RELATED COMPOUND B (30 MG) ( (1-CYANOCYCLOHEXYL) ACETIC ACID) (COLD SHIPMENT) |ESTANDAR DE REFERENCIA PARA PRUEBAS DE LABORATORIO|VP-00298-SP|1287347 | United States | Peru | 1 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA CONSUMO HUMANO , PRESENTACIaN: (EN 10 TABLETS-BLISTER , 50 BLISTERS-BOX ) |LOTE: 656220503 , 656220504 , F. PROD.: 05-2022 , F. VENC.: 05-2025|GABAPENTIN 300MG TABLETS|- | China | Peru | 4614 | | | |
| 3004902900 | GAB-300 300MG CAPSULA|MEDICAMENTO PARA CONSUMO HUMANO|PRODUCTO TERMINADO|LOTE: 22GT003 , VTO.: 12-2024 (CAJA DE 3 X 10 TAB.) (GABAPENTIN TABLETS USP 300MG) | India | Peru | 9169 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA CONSUMO HUMANO , PRESENTACION: (10 TABLETS-BLISTER , 50 BLISTERS-BOX ) |LOTE: 656220301 , 656220302 , 656220303 , 656220304 , 656220305 , 656220306 , 656220307 , 6562203|GABAPENTIN 300 MG TABLET|656220310 , F. PROD.: 03-2022 , VENC.: 03-2025 | China | Peru | 22792 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA CONSUMO HUMANO , PRESENTACION: (10 TABLETS-BLISTER , 50 BLISTERS-BOX ) |LOTE: 656220301 , 656220302 , 656220303 , 656220304 , 656220305 , 656220306 , 656220307 , 6562203|GABAPENTIN 300 MG TABLET|656220310 , F. PROD.: 03-2022 , VENC.: 03-2025 | China | Peru | 22792 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA CONSUMO HUMANO , PRESENTACION: (10 TABLETS-BLISTER , 50 BLISTERS-BOX ) |LOTE: 656220301 , F. PROD.: 03-2022 , VENC.: 03-2025|GABAPENTIN 300 MG TABLET|- | China | Peru | 1132 | | | |
| 3822900000 | GABAPENTINA , USP , S-M|COMPUESTO ORGANICO - LOTE: R056D0|EST-NDARES DE REFERENCIA PARA AN-LISIS EN LABORATORIO.|GABAPENTIN (250MG) -60142-96-3-R056D0-EAR99-2922498050|CODIGO: 1287303 - GABAPENTINA (250 MG) | India | Peru | 1 | | | |
| 3822900000 | GABAPENTINA , USP , S-M|COMPUESTO ORGANICO - LOTE: R056D0|EST-NDARES DE REFERENCIA PARA AN-LISIS EN LABORATORIO.|GABAPENTIN (250MG) -60142-96-3-R056D0-EAR99-2922498050|CODIGO: 1287303 - GABAPENTINA (250 MG) | India | Peru | 1 | | | |
| 3004902900 | GABAPIN 300 GABAPIN S-M|REGISTRO SANITARIO N¦ EE-03129|MEDICAMENTO PARA USO HUMANO ANTIEPILEPTICO|GABAPIN 300 10 CAP (GABAPENTIN USP 300 MG) |LOTE:M2117024 DATE MFG:12-2021 DATE EXP:11-2023 | India | Peru | 17393 | | | |
| 3004902900 | GABAPIN 300 GABAPIN S-M|REGISTRO SANITARIO N¦ EE-03129|MEDICAMENTO PARA USO HUMANO ANTIEPILEPTICO|GABAPIN 300 10 CAP (GABAPENTIN USP 300 MG) |LOTE:M2117024 DATE MFG:12-2021 DATE EXP:11-2023 | India | Peru | 17393 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA CONSUMO HUMANO , PRESENTACION: (10 TABLETS-BLISTER , 50 BLISTERS-BOX ) |LOTE: 656220213 , F. PROD.: 02-2022 , F. VENC.: 02-2025|GABAPENTIN 300 MG TABLETS|- | China | Peru | 808 | | | |
| 3004902900 | GABAPENTINA 300MG , LABOT , S-M|MEDICAMENTO PARA CONSUMO HUMANO , PRESENTACION: (10 TABLETS-BLISTER , 50 BLISTERS-BOX ) |LOTE: 656220213 , F. PROD.: 02-2022 , F. VENC.: 02-2025|GABAPENTIN 300 MG TABLETS|- | China | Peru | 808 | | |
DownloadMarket research report
Market research report
Frequently asked questions
How to study Peru import market of Gabapentin ?
Volza's data of Peru Gabapentin imports allows you to study detailed data with buyer supplier names for last 10 years.
How to create strategy for Peru Gabapentin imports ?
Volza's data of Peru Gabapentin imports helps you create a import strategy from detailed trade data with buyer supplier names, price, volume for last 10 years.
How to find import market intelligence for Gabapentin ?
You can find Peru Gabapentin import market intelligence of last 10 years with buyer, supplier, price and volume from Volza.com
How to new markets for Gabapentin imports ?
You can find New markets for Gabapentin imports from Volza Country wise market report of last 10 years with growth rate, buyer, supplier, price and volume.
Which Gabapentin products are imported from Peru ?
Major products related with Gabapentin are Dosulepin, Dihydroergotamine Mesylate, Chlorpromazine Hydrochloride, Bupropione Hcl, Perphenazine.
What is the HSN code of Gabapentin ?
Top 5 HSN codes for Gabapentin are HSN Code 3004902900 , HSN Code 2922499000, HSN Code 30049081, HSN Code 3822009000, HSN Code 2933799000, You can check for details at https://www.volza.com/hs-codes.
How authentic is data of Peru Gabapentin imports ?
Volza's data of Peru Gabapentin imports is 100% authentic as it is based on actual import export shipments and is collected globally from over 20,000 ports from over 70+ Countries.
How data of Peru Gabapentin imports can help ?
Data of Peru Gabapentin imports contains strategic information and is very useful for importers and exporters who want to expand global trade, improve supply chain of Gabapentin, find economical vendors, new buyers and fast growing markets.
What information does data of Peru Gabapentin imports contains ?
Data of Peru Gabapentin imports contains date of shipment, Name and contact details of importer, exporter, product description, price, quantity, country & port of origin, country & port of destination and many other fields.
How frequently information on Peru Gabapentin imports is updated ?
We update information of Peru Gabapentin imports every month.
Where does Peru imports Gabapentin from ?
As per the Volza's Peru import data of Gabapentin, India accounted for maximum share with 211 shipments followed by China with 194 and United States at 3rd spot with 194 shipments.
Where can I find latest data of Peru Gabapentin imports ?
You can download latest data of Dec-2023 of Peru Gabapentin imports here
Where can I find data of Peru Gabapentin imports with names of buyers & suppliers ?
You can download Volza Peru Gabapentin import data with names of buyers and suppliers.
What is the subscription cost of information on Peru Gabapentin imports ?
There are two options to Subscribe, Online Access starts at $1500 and reports from Volza Consulting starts at $1000.
Whom should I contact with additional questions regarding Peru Gabapentin imports ?
Volza Sales team will be happy to answer your questions, you can reach us at [email protected] or +1-302 786 5213.
2 Ways to avail our services
Online |
|---|
Mode Do it yourself |
Availiblity Instant access |
Cost Access 209+ countries data |
Payment Instant Online |
Data Format Excel |
| View More |
Volza Consulting |
|---|
Mode Customer Order |
Availiblity Starts within 48 hours |
Cost $1000 |
Payment Online and other modes |
Data Format Excel, SQL, MSAcess & Custom |
| View More |
Important Links related to Gabapentin imports
Support
Important Links
Partners
Trade Data
Follow Us:
About Us
Partners
Follow Us: